Abstract Autologous hematopoietic stem cell transplantation (aHSCT) has been used as a therapeutic approach in multiple sclerosis (MS). However, it is still unclear if the immune system that emerges from autologous CD34+ hematopoietic progenitor cells (HPC) of MS patients is pre-conditioned to re-develop the proinflammatory phenotype. The objective of this article is to compare the whole genome gene and microRNA expression signature in CD34+ HPC of MS patients and healthy donors (HD). CD34+ HPC were isolated from peripheral blood of eight MS patients and five HD and analyzed by whole genome gene expression and microRNA expression microarray. Among the differentially expressed genes (DEGs) only TNNT1 reached statistical significance (logFC=3.1, p<0.01). The microRNA expression was not significantly different between MS patients and HD. We did not find significant alterations of gene expression or microRNA profiles in CD34+ HPCs of MS patients. Our results support the use of aHSCT for treatment of MS.

No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients / Lutterotti A; Jelcić I; Schulze C; Schippling S; Breiden P; Mazzanti B; Reinhardt S; Di Gioia M; Repice A; Massacesi L; Sputtek A; Salinas-Riester G; Kroeger N; Sospedra M; Saccardi R; Zander A; Martin R.; Bosi A.. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - ELETTRONICO. - 18 (8):(2012), pp. 1188-1192. [10.1177/1352458511434067]

No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.

MAZZANTI, BENEDETTA;REPICE, ANNA MARIA RITA;MASSACESI, LUCA;BOSI, ALBERTO
2012

Abstract

Abstract Autologous hematopoietic stem cell transplantation (aHSCT) has been used as a therapeutic approach in multiple sclerosis (MS). However, it is still unclear if the immune system that emerges from autologous CD34+ hematopoietic progenitor cells (HPC) of MS patients is pre-conditioned to re-develop the proinflammatory phenotype. The objective of this article is to compare the whole genome gene and microRNA expression signature in CD34+ HPC of MS patients and healthy donors (HD). CD34+ HPC were isolated from peripheral blood of eight MS patients and five HD and analyzed by whole genome gene expression and microRNA expression microarray. Among the differentially expressed genes (DEGs) only TNNT1 reached statistical significance (logFC=3.1, p<0.01). The microRNA expression was not significantly different between MS patients and HD. We did not find significant alterations of gene expression or microRNA profiles in CD34+ HPCs of MS patients. Our results support the use of aHSCT for treatment of MS.
2012
18 (8)
1188
1192
Lutterotti A; Jelcić I; Schulze C; Schippling S; Breiden P; Mazzanti B; Reinhardt S; Di Gioia M; Repice A; Massacesi L; Sputtek A; Salinas-Riester G; ...espandi
File in questo prodotto:
File Dimensione Formato  
No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.pdf

accesso aperto

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Creative commons
Dimensione 794.12 kB
Formato Adobe PDF
794.12 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/848696
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 6
social impact